biosight-pharma.com | BioSight

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Allow: / # Optimization for Google Ads Bot User-Agent: AdsBot-Google-Mobile User-Agent: AdsBot-Google Disallow: /_api/* Disallow: /_partials* Disallow: /pro-gallery-webapp/v1/galleries/*

Meta Tags

Title	BioSight - Innovative Cancer
Description	BioSight is a pharmaceutical development company, developing novel cancer-targeted drugs. BioSight’s BST-236 is developed for acute myeloid leukemia
Keywords	AML acute myeloid leukemia unfit older, BioSight, cancer, chemotherapy, clinical trial, hematology, innovative, oncology

Server Information

WebSite	biosight-pharma.com
Host IP	185.230.63.171
Location	-

Related Websites

                        Site
                        Rank
                    

More to Explore

biosight-pharma.com Valuation

US$4,268,742

Last updated: 2022-06-20 22:13:01

biosight-pharma.com has Semrush global rank of 2,479,490. biosight-pharma.com has an estimated worth of US$ 4,268,742, based on its estimated Ads revenue. biosight-pharma.com receives approximately 492,548 unique visitors each day. Its web server is located in -, with IP address 185.230.63.171. According to SiteAdvisor, biosight-pharma.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$4,268,742
Daily Ads Revenue	US$3,941
Monthly Ads Revenue	US$118,212
Yearly Ads Revenue	US$1,418,536
Daily Unique Visitors	32,837
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
biosight-pharma.com.	A	3599	IP: 185.230.63.171
biosight-pharma.com.	A	3599	IP: 185.230.63.107
biosight-pharma.com.	A	3599	IP: 185.230.63.186
biosight-pharma.com.	NS	86400	NS Record: ns3.wixdns.net.
biosight-pharma.com.	NS	86400	NS Record: ns2.wixdns.net.
biosight-pharma.com.	MX	3600	MX Record: 10 biosightpharma-com02b.mail.protection.outlook.com.
biosight-pharma.com.	TXT	3600	TXT Record: v=spf1 include:spf.protection.outlook.com -all
biosight-pharma.com.	TXT	3600	TXT Record: google-site-verification=MQPRAkW0Dial7Aow_dlRM5tGTsyNlbyH19pWTwQYxqg
biosight-pharma.com.	TXT	3600	TXT Record: MS=ms68343393

HtmlToTextCheckTime:2022-06-20 22:13:01

Home Overview Board of Directors Management Team Clinical Advisory Board Aspacytarabine (BST-236) Publications Intellectual Property News Contact Innovative Therapeutics for Oncology & Hematological Disorders Biosight is dedicated to providing hope and cure to cancer patients around the world We seek to develop advanced therapeutics to enable safer and more effective treatment for life-threatening diseases, to improve the outcome and quality of life for patients with cancer and related diseases © 2021 by BioSight

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Sat, 23 Oct 2021 11:48:17 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.biosight-pharma.com/
strict-transport-security: max-age=120
Age: 5264
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=42
X-Seen-By: 6ivkWfREES4Y8b2pOpzk7Owfbs+7qUVAqsIx00yI78k=,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjV6gLktDfyBcCbzwqWl25/,m0j2EEknGIVUW/liY8BLLkiHzpTYSDRA7u88Ic3Fde7F+NHRbelhY0dsZwjDYnLI,2d58ifebGbosy5xc+FRalisHYWxPyXTdkvj5Sae7i9ZIyIo3lJDnFt3VcRvEpPRbR8Y50k+nHVdCUZnHm6clRw==,2UNV7KOq4oGjA5+PKsX47O2a5xgRLfGhgyjJBLXaH1ZYgeUJqUXtid+86vZww+nL
Cache-Control: no-cache
X-Wix-Request-Id: 1634989697.467295154487629394
X-Content-Type-Options: nosniff

HTTP/2 200 
alt-svc: h3=":443";ma=86400,h3-29=":443";ma=86400,h3-27=":443";ma=86400
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1634989697.5902304753185305
content-language: en
strict-transport-security: max-age=120
age: 0
accept-ranges: bytes
cache-control: private,max-age=0,must-revalidate
x-content-type-options: nosniff
server: Pepyaka/1.19.10
date: Sat, 23 Oct 2021 11:48:17 GMT
x-served-by: cache-chi21173-CHI
x-cache: MISS
vary: Accept-Encoding
server-timing: cache;desc=miss, varnish;desc=miss_miss, dc;desc=fastly
set-cookie: ssr-caching=cache#desc=miss#varnish=miss_miss#dc#desc=fastly; Max-Age=20; Expires=Sat, 23 Oct 2021 11:48:37 GMT
x-seen-by: roqoaVaG/Y0K4FDXPQbYVA==,GXNXSWFXisshliUcwO20NYMupe6WQf6MVMrzEUOojIJApWd1FlscnvvmzjBAZbfy,qquldgcFrj2n046g4RNSVI5y0OKACGwHEq+Bmxf53RlYgeUJqUXtid+86vZww+nL,2d58ifebGbosy5xc+FRaliHa20vZaJmhLZ3bZIueodEuVR39s0160+4lpzIBRZe+xBgV2YMssOpkse4xD3oKNDJImUJnVwMFmMnQYQonuBU=,2UNV7KOq4oGjA5+PKsX47EPxNtZAQGoUGD8v2MHQKAJYgeUJqUXtid+86vZww+nL,YO37Gu9ywAGROWP0rn2IfgW5PRv7IKD225xALAZbAmk=,UvY1uiXtmgas6aI2l+unv6fibX9HQcAFB45R3mCgHZkY56ggdJAV5y6zh+JRIUSmWIHlCalF7YnfvOr2cMPpyw==,dvEkI3CoQ26/kOBf/eu3DHKTRSvcnY4cFS879Zaqy8gaWyug/ZdHQ36uOAkr89T0,qJS91GsscGZlb16v+8nwmLkTHf5uZ9iSHcFIOcX2q8NGp/J3MBzgzU8QHrQuh4zQ,LoUK8/saGAmOxZWtpubo2iTOnK3GmbK6QcBXwd5Fv/obN0Oc5gZ84DM5YAais+QyV9d6bl4+z6ce1mPaifKRLg==,qJS91GsscGZlb16v+8nwmLkTHf5uZ9iSHcFIOcX2q8NGp/J3MBzgzU8QHrQuh4zQ,JLaio/7uvfP647F5CQsGZTiuYheDSAI10M5YCrzQ3QBGp/J3MBzgzU8QHrQuh4zQ,/a5ccLSK1HEmwPNg/x6OujZ3nNzPi/JTVZTtFE8718YTcEjqzReD3Ciy7qXxhXgiBVQ/8lnWxvUaJKIjUfQ72Q==

biosight-pharma.com Whois Information

Domain Name: BIOSIGHT-PHARMA.COM
Registry Domain ID: 1894708321_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.networksolutions.com
Registrar URL: http://networksolutions.com
Updated Date: 2020-10-13T05:13:01Z
Creation Date: 2015-01-08T11:31:15Z
Registry Expiry Date: 2023-01-08T11:31:15Z
Registrar: Network Solutions, LLC
Registrar IANA ID: 2
Registrar Abuse Contact Email: abuse@web.com
Registrar Abuse Contact Phone: +1.8003337680
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: NS2.WIXDNS.NET
Name Server: NS3.WIXDNS.NET
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-11T22:49:55Z <<<

biosight-pharma.com valuation and analysis